Year: 2019

Sygnum and Amun launch innovative digital asset index for the next generation Internet – the Internet of ValueA new Exchange Traded Product (ETP) is listed on the SIX exchange to track the Amun Sygnum Platform Winners Index. This ETP is a useful vehicle to gain passive exposure to foundational blockchain protocols, as well as a convenient, safe entry point for investors new to digital assets.Zürich, 05 December 2019 – Sygnum, the world’s first digital asset bank, in collaboration with Amun AG, the largest provider of Exchange Traded Products in the digital asset industry, have launched a new digital asset index. The corresponding ETP, called the Amun Sygnum Platform Winners Index ETP (ticker: MOON) begins trading on the SIX exchange today. This ETP enables all types of investors to gain exposure to digital assets in a convenient, safe and...

Basel, December 5, 2019 — Novartis AG (NYSE: NVS) (“Novartis”) today announced that its indirect wholly-owned subsidiary, Medusa Merger Corporation, a Delaware corporation (“Purchaser”), has commenced a cash tender offer to purchase all of the outstanding shares of common stock, par value USD 0.001 per share, of The Medicines Company (NASDAQ: MDCO) for a price of USD 85.00 per share, net to the seller in cash, without interest and subject to any tax withholding (the “Offer”).  The Offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase, dated December 5, 2019, and the related Letter of Transmittal and pursuant to the terms of the previously announced Agreement and Plan of Merger, dated as of November 23, 2019 (the “Merger Agreement”), among Novartis, Purchaser and The Medicines Company.The Offer...

Allschwil, Switzerland – December 5, 2019 Idorsia Ltd (SIX: IDIA) and Mochida Pharmaceutical Co., Ltd. today announced that they have entered into an exclusive license agreement for the supply, co-development and co-marketing of daridorexant, Idorsia’s dual orexin receptor antagonist (DORA), for insomnia and related disorders in Japan.Idorsia will receive an initial payment of 1 billion Japanese yen (approximately 9 million Swiss francs) and will be entitled to three additional development and regulatory milestones. Idorsia will also be entitled to sales milestones and tiered royalty payments based on net sales achieved by Mochida. Costs associated with the co-development of daridorexant will be shared.With regards to the future development program, Idorsia will be responsible for the design and conduct of additional preclinical and clinical...

–Early reports already impacting decisions resultingin projected process efficiencies and cost savingsVANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce it has received a phase 1 project profile report and has been advised that the project characterization project is fully underway and moving ahead on schedule.As previously announced, Isracann engaged the services of LinC by Growing Smart Ltd., an international agricultural management company with extensive experience and expertise within the cannabis sector in Israel. The firm specializes in the delivery of individually...

ROAD TOWN, British Virgin Islands, Dec. 04, 2019 (GLOBE NEWSWIRE) — Aura Minerals Inc. (“Aura” or the “Company”) (TSX:ORA) announced today that on November 25, 2019, in compliance with a court order, local authorities seized the equipment of Incobe, the main contractor at the Company’s San Andres mine in Honduras. Minerales de Occidente, S.A. de C.V. (“Minosa”), a wholly-owned subsidiary of Aura, owns the surface and mineral rights at the San Andres mine.On December 3, 2019, Minosa was officially notified of the seizure by such authorities.  The reasons for the seizure of Incobe’s equipment are wholly unrelated to Aura or Incobe’s work at the San Andres mine.Also on December 3, 2019, Minosa signed a Memorandum of Understanding with Constructora Cordon’s Heavy Equipment S. de R.L., a major company in Honduras, which is mobilizing...

All amounts in U.S. dollars unless otherwise statedTORONTO and HONG KONG, Dec. 04, 2019 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX), Baring Private Equity Asia (“BPEA”) and their affiliated funds (together the “Group”), today announced the sale of 43.2 million ordinary shares of Clarivate Analytics plc (“Clarivate”) (NYSE: CCC; CCC.WS) at an offering price of $17.25 per share.  The underwriters were granted a 30‑day option to purchase up to 6.48 million additional ordinary shares from the Group.  Clarivate is a global leader in providing trusted insights and analytics to accelerate the pace of innovation.At the offering price and before the underwriters’ option, gross proceeds to the Group will be approximately $745 million, of which Onex’ share will be approximately $203 million as a Limited Partner in Onex Partners...

MORRIS PLAINS, N.J., Dec. 04, 2019 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced the pricing of an underwritten public offering of 14,285,715 shares of its common stock at a public offering price of $17.50 per share, representing gross proceeds of approximately $250 million. In addition, Immunomedics has granted the underwriters a 30-day option to purchase up to 2,142,857 additional shares of common stock. The offering is expected to close on or about December 9, 2019, subject to customary closing conditions.Immunomedics intends to use the net proceeds from this offering primarily to accelerate commercial launch readiness, pending FDA approval, of sacituzumab govitecan in the United States...

CALGARY, Alberta, Dec. 04, 2019 (GLOBE NEWSWIRE) — Baytex Energy Corp. (“Baytex”) (TSX, NYSE: BTE) announces that its Board of Directors has approved a 2020 capital budget of $500 to $575 million, which is designed to generate average annual production of 93,000 to 97,000 boe/d. The Board of Directors is also pleased to announce the appointment of Mark Bly as Chairman.Commenting on the budget announcement, Ed LaFehr, President and Chief Executive Officer, said: “We continue to deliver on our 2019 plan with projected free cash flow of $300 million. As in 2019, our capital program for 2020 is designed to deliver stable production, maximize free cash flow and further strengthen our balance sheet. We will remain disciplined with capital allocation, focusing on our high netback light oil assets in the Viking and Eagle Ford and our capital...